Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Six versus twelve months of clopidogrel after second-generation drug-eluting stent implantation
2008-007526-19Phase 4Terminated
- Sponsor
- Fondazione Evidence
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary arteriosclerosis, angina pectoris and unstable angina (2 arms), sponsored by Fondazione Evidence. Started Apr 2009; status: terminated.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosisangina pectorisunstable angina
Beyond the preview
Go deeper on 2008-007526-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007526-19.